Nifty Pharma Today: Index Gains 0.08% in Opening Trade

Updated: 17 Aug 2026 • 10:02 am

Posted by:

Nifty Pharma Today: Index Gains 0.08% in Opening Trade

Quick sector takeaways

Nifty Pharma rose 0.08%, or 21.10 points, to 26,466.65 in the early session on 17 August 2026.
The index was above its previous close of 26,445.55, after trading between 26,435.40 and 26,537.35 during the session so far.
Breadth was mixed: 8 of 20 tracked stocks advanced, 11 declined and 1 was unchanged. Ipca Laboratories was the standout gainer, while JB Chemicals & Pharmaceuticals saw the sharpest decline.
Investors tracking nifty pharma today can watch whether the index sustains above its previous close and whether participation broadens beyond a handful of gainers.

Nifty Pharma today: early-session update

Nifty Pharma today is modestly positive in opening trade, with the sector index up 21.10 points, or 0.08%, at 26,466.65 as of 17 August 2026 at 10:00:03 AM IST. The reading places the index marginally above the previous close of 26,445.55, signalling a positive index-level start without a broad-based advance across the sector’s tracked stocks.

The session has so far shown movement on both sides of the opening level. Nifty Pharma opened at 26,528.00, moved to an intraday high of 26,537.35 and touched a low of 26,435.40. The latest value is below the opening level but remains above the previous close. This makes the early reading constructive at the index level, while also highlighting that stock-specific performance is varied.

The index is the second top gaining sector index among the configured sector indices in this update. Its 0.08% gain trails Nifty Metal’s 0.29% rise and is ahead of Nifty Auto’s 0.07% increase. The ranking gives Nifty Pharma a place among the limited set of sectors holding positive territory in the opening phase.

Price snapshot

Measure	Level	Reading
Last traded price	26,466.65	Up 21.10 points
Previous close	26,445.55	Base for the day’s 0.08% gain
Day open	26,528.00	Above the previous close
Day high	26,537.35	Early-session peak so far
Day low	26,435.40	Below the previous close

The current level sits 70.70 points below the day high and 31.25 points above the day low. The index’s intraday range is 101.95 points so far. As the index trades close to its previous close, subsequent movement around that reference point may remain important for assessing whether the initial gain develops into a firmer sector move.

Sector ranking

Within the configured sector-index universe, Nifty Pharma ranks as the second top gainer in the early session. Nifty Metal leads with a 0.29% gain, followed by Nifty Pharma at 0.08% and Nifty Auto at 0.07%. By comparison, Nifty IT is down 1.37%, Nifty FMCG is lower by 0.49%, Nifty Bank has declined 0.36%, Nifty Financial Services is down 0.32%, and Nifty Mid Select is lower by 0.25%.

This ranking is based on the actual percentage movement of the sector indices at the stated timestamp. A second-place position is useful context for the pharma move, but the narrow 0.08% advance indicates that the index’s outperformance is measured rather than decisive.

Constituent breadth

Sector breadth presents a more mixed picture than the headline index gain. Of the 20 displayed Nifty Pharma stocks, 8 were advancing, 11 were declining and 1 was unchanged. The advance-decline ratio stood at 0.73, meaning decliners outnumbered advancers even as the index remained in positive territory.

This combination shows that the index’s small gain was not accompanied by majority participation. Individual moves in select stocks were sufficient to keep the sector index above its previous close, while a larger number of stocks traded lower. For nifty pharma today, tracking the balance between advancing and declining stocks through the session can add context to the index level.

Heavyweights versus broader participation

The named heavyweight stocks showed divergent movement. Sun Pharmaceutical Industries fell 0.77% to 1,915.20, Cipla declined 0.89% to 1,437.10, and Dr. Reddy’s Laboratories was down 0.52% at 1,193.80. Torrent Pharmaceuticals was unchanged at 4,833.00. In contrast, Divi’s Laboratories gained 0.60% to 8,528.00.

The same set of names also features in the supplied active-stock list, making their price action relevant to the early sector reading. Divi’s Laboratories provided a positive counterpoint, while declines in Sun Pharmaceutical Industries, Cipla and Dr. Reddy’s Laboratories underlined the mixed nature of participation. Torrent Pharmaceuticals holding flat added another neutral element to the heavyweight picture.

Key Nifty Pharma stocks

Stock	Move	Why it matters
Ipca Laboratories	Up 7.71% to 1,867.90	The strongest percentage gainer among the displayed stocks.
JB Chemicals & Pharmaceuticals	Down 3.87% to 2,408.90	The largest percentage decline among the displayed stocks.
Aurobindo Pharma	Up 1.39% to 1,644.70	One of the leading positive contributors by percentage move.
Laurus Labs	Up 1.25% to 1,809.60	Added to the positive side of early sector participation.
Alkem Laboratories	Up 1.24% to 5,434.50	Joined the leading gainers despite mixed overall breadth.
Biocon	Down 1.77% to 409.60	Among the sharper declines in the displayed basket.

Biggest positive movers

Ipca Laboratories led the gainers, rising 7.71% to 1,867.90 after trading between 1,805.90 and 1,945.10. Aurobindo Pharma added 1.39% to 1,644.70, while Laurus Labs rose 1.25% to 1,809.60. Alkem Laboratories gained 1.24% to 5,434.50 and Ajanta Pharma advanced 0.95% to 3,707.70.

These advances provided the positive side of the sector’s early-session performance. Ipca Laboratories’ move was materially larger than the other displayed gainers, making it the most prominent stock-level change in the basket at the timestamp.

Biggest negative movers

JB Chemicals & Pharmaceuticals declined 3.87% to 2,408.90, following an intraday range of 2,380.00 to 2,525.50. Biocon fell 1.77% to 409.60, while Abbott India was down 1.35% at 26,695.00. Natco Pharma declined 1.27% to 891.65 and Granules India slipped 0.98% to 850.00.

The losses among these names explain why the positive index reading did not translate into positive breadth. Their movements also reinforce that the sector’s 0.08% gain should be viewed alongside the uneven distribution of stock returns.

Stocks to watch next session

Ipca Laboratories: Its 7.71% gain and wide early intraday range make it a key stock to monitor.
JB Chemicals & Pharmaceuticals: The 3.87% decline places it at the centre of the sector’s negative movers.
Aurobindo Pharma: The stock rose 1.39% and traded close to its day high of 1,652.00.
Divi’s Laboratories: Its 0.60% gain contrasted with declines in several heavyweight peers.
Sun Pharmaceutical Industries: Its 0.77% fall remains relevant given its place among the named heavyweight stocks.
Biocon: The 1.77% decline makes its subsequent price action worth tracking.

The constructive case

The constructive evidence is clear but modest. Nifty Pharma is above its previous close, ranks second among the configured sector gainers, and has recorded an early high above its opening level. Positive moves in Ipca Laboratories, Aurobindo Pharma, Laurus Labs, Alkem Laboratories, Ajanta Pharma, Glenmark Pharmaceuticals, Divi’s Laboratories and Gland Pharma have supported the index.

The index also remains above its intraday low of 26,435.40 at the stated time. That position, together with the positive close-to-current comparison, keeps the immediate index reading positive. However, the size of the gain remains limited at 0.08%.

The cautious case

The cautious case rests on breadth and the index’s position below its opening level. With 11 decliners against 8 advancers, the stock-level picture is tilted towards losses. Several named heavyweight stocks, including Sun Pharmaceutical Industries, Cipla and Dr. Reddy’s Laboratories, are trading lower, while Torrent Pharmaceuticals is unchanged.

Nifty Pharma has also moved down from its day high of 26,537.35 and is below the 26,528.00 opening mark. The sector is still positive versus the previous close, but the mixed composition means that confirmation from broader participation would be needed to make the early gain more inclusive.

Univest Insights

The early-session picture for nifty pharma today is one of restrained index strength alongside divergent constituent action. The 0.08% rise gives the sector a favourable rank among configured indices, but it does not by itself establish broad momentum across the basket.

Ipca Laboratories is the defining positive outlier, while JB Chemicals & Pharmaceuticals is the defining negative outlier. The gap between these moves shows how individual stock performance can shape the sector conversation even when the aggregate index change is small.

Heavyweight action adds balance rather than a singular direction: Divi’s Laboratories is higher, Torrent Pharmaceuticals is flat, and Sun Pharmaceutical Industries, Cipla and Dr. Reddy’s Laboratories are lower. Readers can follow the wider market context through Univest Market View.

For traders and investors, the key signal to watch is whether Nifty Pharma holds above its previous close while the number of advancing stocks improves.

Published on 17 August 2026 at 10:01 AM IST

Frequently asked questions

What is Nifty Pharma today?

Nifty Pharma was at 26,466.65, up 21.10 points or 0.08%, as of 10:00:03 AM IST on 17 August 2026.

What was the Nifty Pharma previous close?

The previous close for Nifty Pharma was 26,445.55.

What were the day high and day low for Nifty Pharma?

The day high was 26,537.35 and the day low was 26,435.40 at the stated timestamp.

Why is Nifty Pharma the second top gaining sector index?

Nifty Pharma gained 0.08%, placing it second among the configured sector indices, behind Nifty Metal’s 0.29% rise.

Which Nifty Pharma stock gained the most today?

Ipca Laboratories was the top displayed gainer, rising 7.71% to 1,867.90.

How was Nifty Pharma breadth in early trade?

Of 20 displayed stocks, 8 advanced, 11 declined and 1 was unchanged.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.